Gabather Joins Forces with the Centre for Neuropsychiatric Schizophrenia Research in Denmark to Conduct a Clinical Phase II Study with GT-002 ...Middle East

STOCKHOLM, April 10, 2024 /PRNewswire/ -- Gabather AB (Nasdaq First North Growth Market: GABA) announces that the Company has signed a Collaborative Agreement with the Centre for Neuropsychiatric Schizophrenia Research at the Psychiatric Centre in Glostrup to conduct a so-called clinical...

Hence then, the article about gabather joins forces with the centre for neuropsychiatric schizophrenia research in denmark to conduct a clinical phase ii study with gt 002 was published today ( Wednesday 10/04/2024 - 02:21 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Gabather Joins Forces with the Centre for Neuropsychiatric Schizophrenia Research in Denmark to Conduct a Clinical Phase II Study with GT-002 )

Also on site :

• Goldfish Is Offering Fans Free Crackers for Tax Day—Here’s How To Claim Yours
• The Strange GLP-1 Side Effect Plaguing Patients Months After Starting
• Man injured in Hove pub shooting